2m 2m 2m 2m 2m 2m 2m
Veracyte (VCYT)
NASDAQ
$52.98-$0.21 (-0.39%)
Price as of Jun 23, 2026 6:42 PM EDT- $4.2BMarket Cap
- 99.14%1-Year Change
- Diagnostics & ResearchIndustry
Veracyte (VCYT)
$52.98-$0.21 (-0.39%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 16.51% | 13.2M | +43,817 (+0.33%) | Mar 31, 2026 |
VANGUARD GROUP INC | 10.66% | 8.5M | -77 (-0.0009%) | Dec 31, 2025 |
BLACKROCK INC. | 9.77% | 7.8M | +581,688 (+7.46%) | Jun 30, 2024 |
FMR LLC | 9.73% | 7.8M | +2.0M (+26.09%) | Mar 31, 2026 |
BLACKROCK FUNDING, INC. /DE | 9.43% | 7.5M | -111,686 (-1.48%) | Dec 31, 2024 |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 6.89% | 5.5M | -766,671 (-13.95%) | Mar 31, 2026 |
WELLINGTON MANAGEMENT CO LLP | 6.37% | 5.1M | +9,476 (+0.19%) | Dec 31, 2021 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
iSHARES TRUST | 10.92% | 8.7M | -18,431 (-0.21%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 7.83% | 6.2M | +113,400 (+1.81%) | Mar 31, 2026 |
Ark ETF Trust | 4.18% | 3.3M | -659,205 (-19.77%) | Jan 30, 2026 |
SPDR SERIES TRUST | 3.89% | 3.1M | +582,442 (+18.76%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.62% | 2.1M | +47,706 (+2.29%) | Feb 28, 2026 |
FIRST TRUST EXCHANGE-TRADED FUND | 2.40% | 1.9M | +790,123 (+41.19%) | Mar 31, 2026 |
ARTISAN PARTNERS FUNDS INC | 2.05% | 1.6M | -298,792 (-18.29%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions1.5B (74.48%)
- Mutual Funds491.5M (25.14%)
- Insiders7.3M (0.37%)
- Other0 (0.00%)
Insider Transactions
- 0.37% (7.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 10Number of InsiderSelling (last 12 months)
- $107.8MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
EASTHAM KARIN | Sell | Jun 18, 2026 | $168,906.24 | 3,200 | $52.78 | 15,626 |
EASTHAM KARIN | Sell | Jun 18, 2026 | $28,328.16 | 529 | $53.55 | 15,097 |
EASTHAM KARIN | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 18,826 |
Barr Eliav | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 56,461 |
Shafer David Brent | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 31,100 |
JONES EVAN/ FA | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 34,634 |
Bhanji Muna | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 44,582 |
Miller Thomas F. | Award | Jun 11, 2026 | $0.00 | 5,272 | $0.00 | 31,100 |
McGuire Annie SVP, General Counsel | Award | Mar 06, 2026 | $0.00 | 32,892 | $0.00 | 127,598 |
Wygant Jonathan VP, Chief Accounting Officer | Award | Mar 06, 2026 | $0.00 | 10,525 | $0.00 | 45,434 |
McGuire Annie SVP, General Counsel | Award | Mar 06, 2026 | $0.00 | 26,314 | $0.00 | 153,912 |
Leite John Chief Commercial Officer-CLIA | Award | Mar 06, 2026 | $0.00 | 36,181 | $0.00 | 143,761 |
Febbo Phillip G. Chief Scientific & Med Officer | Award | Mar 06, 2026 | $0.00 | 29,603 | $0.00 | 146,949 |
Leite John Chief Commercial Officer-CLIA | Award | Mar 06, 2026 | $0.00 | 6,578 | $0.00 | 150,339 |
Febbo Phillip G. Chief Scientific & Med Officer | Award | Mar 06, 2026 | $0.00 | 6,578 | $0.00 | 153,527 |
Stapley Marc Chief Executive Officer | Sell | Mar 04, 2026 | $684,226.19 | 19,244 | $35.56 | 383,833 |
Chambers Rebecca Chief Financial Officer | Sell | Mar 04, 2026 | $156,409.44 | 4,400 | $35.55 | 145,137 |
Stapley Marc Chief Executive Officer | Sell | Mar 04, 2026 | $953,367.96 | 26,279 | $36.28 | 357,554 |
McGuire Annie SVP, General Counsel | Sell | Mar 04, 2026 | $176,256.24 | 4,994 | $35.29 | 96,370 |
Leite John Chief Commercial Officer-CLIA | Sell | Mar 04, 2026 | $185,082.57 | 5,260 | $35.19 | 107,580 |
McGuire Annie SVP, General Counsel | Sell | Mar 04, 2026 | $60,468.60 | 1,664 | $36.34 | 94,706 |
Chambers Rebecca Chief Financial Officer | Sell | Mar 04, 2026 | $506,459.80 | 13,941 | $36.33 | 131,196 |
Wygant Jonathan VP, Chief Accounting Officer | In Kind | Mar 02, 2026 | $108,246.06 | 3,006 | $36.01 | 34,909 |
Chambers Rebecca Chief Financial Officer | In Kind | Mar 02, 2026 | $260,496.34 | 7,234 | $36.01 | 149,537 |
Leite John Chief Commercial Officer-CLIA | In Kind | Mar 02, 2026 | $270,687.17 | 7,517 | $36.01 | 112,840 |
Stapley Marc Chief Executive Officer | In Kind | Mar 02, 2026 | $700,574.55 | 19,455 | $36.01 | 403,077 |
Febbo Phillip G. Chief Scientific & Med Officer | In Kind | Mar 02, 2026 | $217,320.35 | 6,035 | $36.01 | 130,771 |
McGuire Annie SVP, General Counsel | In Kind | Mar 02, 2026 | $248,541.02 | 6,902 | $36.01 | 101,364 |
Febbo Phillip G. Chief Scientific & Med Officer | Sell | Mar 02, 2026 | $485,429.21 | 13,425 | $36.16 | 117,346 |
Febbo Phillip G. Chief Scientific & Med Officer | Award | Feb 26, 2026 | $0.00 | 71,806 | $0.00 | 161,292 |